![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Jamie Tallon
Jamie is Director of Product Innovation at ICON and has more than 15 years’ experience in the CRO environment and began his career in Data Management, leading the protocol interpretation, CRF and eCRF development of over 300 studies across clinical phase’s I-IV, before working with ICON Central Laboratories in developing global standards. Jamie then took the opportunity to work in IT as a Solutions Specialist Architect focusing on Enterprise Portal and Content Management strategy and solutions. The last 4 years Jamie has been a member of the ICON Innovation group creating, developing and implementing ICON’s global innovation model, process and methodologies.
Company:ICON plc
ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to the pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 90 locations in 37 countries and has approximately 13,680 employees.
